Basit öğe kaydını göster

dc.contributor.authorBulut, Muhammet
dc.contributor.authorDindar, Aygün
dc.contributor.authorNisli, Kemal
dc.date.accessioned2021-12-10T10:05:17Z
dc.date.available2021-12-10T10:05:17Z
dc.date.issued2020
dc.identifier.citationBulut M., Nisli K., Dindar A., "The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center", ANNALS OF PEDIATRIC CARDIOLOGY, cilt.13, sa.2, ss.111-116, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_2812cbc1-0bb8-4e1b-ba79-f4263a2b74fa
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169159
dc.identifier.urihttps://doi.org/10.4103/apc.apc_56_19
dc.description.abstractIntroduction : Familial hypercholesterolemia (FH) is characterized by severe hypercholesterolemia that can result in coronary artery disease occurring at an early age. If patients are not cured with lipid-lowering drugs and diets, lipid apheresis may be an effective treatment option in these cases. Here, we evaluate the efficacy, selectivity and safety of the DALI apheresis technique.
dc.language.isoeng
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectKardiyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleThe effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
dc.typeMakale
dc.relation.journalANNALS OF PEDIATRIC CARDIOLOGY
dc.contributor.departmentGiresun Üniversitesi , ,
dc.identifier.volume13
dc.identifier.issue2
dc.identifier.startpage111
dc.identifier.endpage116
dc.contributor.firstauthorID2606610


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster